Related Experiment Video
Updated: Jun 3, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitis
Aránzazu Jáuregui-Amézaga1, Elena Ricart, Julián Panés
1Department of Gastroenterology, Hospital Clínic de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.
Treatment strategies for Crohn's disease may inform ulcerative colitis (UC) care. Topical aminosalicylates may work for UC, while high-dose corticosteroids and long-term thiopurines are effective. Anti-TNF therapy with maintenance is optimal.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Crohn's disease (CD) historically received more research focus than ulcerative colitis (UC).
- Existing CD treatment data can guide UC management decisions.
- Aminosalicylates may have topical efficacy in UC, unlike in CD.
Purpose of the Study:
- To review and adapt treatment strategies from Crohn's disease for ulcerative colitis.
- To highlight drug efficacy and safety considerations for UC patients.
Main Methods:
- Review of aminosalicylate, corticosteroid, thiopurine, and anti-TNF antibody therapies.
- Analysis of treatment optimization, duration, and combination strategies.
- Consideration of patient-specific factors like age and EBV status.
Main Results:
- High-dose corticosteroids (1 mg/kg/day) are most effective for UC remission.
- Thiopurines offer steroid-sparing effects over at least 4 years; caution advised in specific populations.
- Scheduled anti-TNF antibody induction and maintenance therapy improves outcomes and reduces immunogenicity.
Conclusions:
- Topical aminosalicylates may be effective for UC.
- Optimized corticosteroid and thiopurine use, with careful monitoring, is recommended.
- Combined therapies and stopping anti-TNF treatment require further UC-specific investigation.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Ulcerative Colitis
